https://www.selleckchem.com/pr....oducts/cd38-inhibito
For pN2/N3 patients, 38% were identified as cN0. Mammogram sensitivity was 10%; ultrasound 42%; MRI 65%. Pathology evaluation of N2/N3 patients indicated LN were replaced with ILC but maintained normal architecture. The average largest pathologic tumor deposit (1.5 ± 0.8cm) correlated with average largest imaging LN size (1.4 ± 0.6cm) (p = 0.58). A statistically significant difference between clinical and pathologic N-stage exists for ILC patients. MRI was most sensitive for identification of pN2-N3 patients and should be consi
Like
Comment
Share
